• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 5. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Professional Introduction to Compound with CAS No. 176967-80-9 and Product Name: 5-Bromo-8-nitroquinoline

5-Bromo-8-nitroquinoline, identified by the Chemical Abstracts Service (CAS) number 176967-80-9, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline family, a class of molecules known for their broad spectrum of biological activities and utility in drug development. The structural features of 5-Bromo-8-nitroquinoline, including the presence of both bromine and nitro substituents, make it a versatile intermediate in synthetic chemistry and a promising candidate for further exploration in medicinal applications.

The quinoline scaffold is a privileged structure in drug discovery, with numerous examples of quinoline derivatives exhibiting antimicrobial, antimalarial, anticancer, and anti-inflammatory properties. The introduction of halogen atoms, such as bromine at the 5-position and nitro at the 8-position, enhances the reactivity and electronic properties of the molecule, opening up possibilities for diverse chemical modifications and biological evaluations. These modifications can fine-tune the pharmacokinetic and pharmacodynamic profiles of the compound, making it an attractive scaffold for developing novel therapeutic agents.

In recent years, there has been a surge in research focused on quinoline derivatives due to their potential in addressing emerging infectious diseases and chronic conditions. The 5-Bromo-8-nitroquinoline molecule has been studied for its interactions with various biological targets, including enzymes and receptors involved in pathogenic processes. Preliminary studies suggest that this compound may exhibit inhibitory activity against certain enzymes that are overexpressed in cancer cells, making it a candidate for further investigation as an anticancer agent.

The bromine substituent at the 5-position of the quinoline ring provides a handle for further functionalization through cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions allow for the introduction of aryl or heteroaryl groups, expanding the structural diversity of derivatives derived from 5-Bromo-8-nitroquinoline. Similarly, the nitro group at the 8-position can be reduced to an amine or further functionalized to introduce other pharmacophores. Such chemical versatility makes this compound a valuable building block in medicinal chemistry.

Advances in computational chemistry have also facilitated the design of novel derivatives of 5-Bromo-8-nitroquinoline by predicting their binding affinities to biological targets. Molecular docking studies have identified potential interactions between this compound and proteins involved in signal transduction pathways relevant to diseases such as cancer and inflammation. These computational insights have guided experimental efforts to optimize the structure-activity relationships (SAR) of quinoline derivatives.

The synthesis of 5-Bromo-8-nitroquinoline involves multi-step organic transformations that highlight its synthetic utility. The bromination step typically employs bromine or N-bromosuccinimide (NBS) under controlled conditions to introduce the bromine atom at the 5-position. Subsequent nitration using a mixture of nitric acid and sulfuric acid yields the 8-nitro derivative. These reactions require careful optimization to ensure high yields and purity, which are critical for pharmaceutical applications.

Recent research has also explored the pharmacological properties of 5-Bromo-8-nitroquinoline in preclinical models. Studies have demonstrated its potential as an inhibitor of kinases that play a role in tumor growth and metastasis. The ability of this compound to modulate kinase activity has opened up avenues for developing targeted therapies against specific cancer types. Additionally, its interaction with other cellular components has been investigated for possible applications in treating inflammatory diseases.

The development of new synthetic methodologies has further enhanced the accessibility of 5-Bromo-8-nitroquinoline derivatives. Catalytic processes have been developed to streamline key transformations, reducing reaction times and improving atom economy. These advancements have enabled researchers to explore larger libraries of derivatives more efficiently, accelerating the discovery process.

In conclusion, 5-Bromo-8-nitroquinoline (CAS No. 176967-80-9) represents a promising scaffold for pharmaceutical innovation. Its unique structural features, combined with its synthetic versatility, make it an attractive candidate for developing novel therapeutic agents. Ongoing research continues to uncover new biological activities and synthetic possibilities, positioning this compound as a cornerstone in modern drug discovery efforts.

• 344286-99-3(7-Bromo-8-nitroquinoline)
• 210708-23-9(3-Bromo-6-methyl-8-nitroquinoline)
• 326798-95-2(5-bromo-6-methyl-8-nitroquinoline)
• 68527-67-3(6-Bromo-8-nitroquinoline)
• 5341-07-1(3-Bromo-8-nitroquinoline)
• 397864-11-8(3-Bromo-7-nitro-1H-indole)
• 165669-16-9(5-Bromo-7-nitro-1H-indole)
• 860195-53-5(4-Bromo-6-nitroquinoline)
• 933486-43-2(4-Bromo-7-nitroquinoline)
• 36255-28-4(6-Bromo-3-nitroquinoline)